07/29/2026
Scientists Found a Switch That Turns Off Fat Storage — And Turns On Fat Burning:
While modern weight-loss medications like GLP-1 agonists have taken the world by storm, they frequently come with a major downside: the loss of critical lean muscle mass along with fat.
To tackle this, researchers at the Weizmann Institute of Science investigated the MTCH2 protein—nicknamed 'Mitch'—which acts as a metabolic gatekeeper. Building on prior animal studies where mice lacking 'Mitch' became highly resistant to obesity and exceptionally athletic, scientists used genetic engineering to silence the protein in human cells.
By shutting down MTCH2, they successfully triggered a rapid, permanent state of cellular energy demand that forced human cells to burn fats and carbohydrates at an accelerated rate.
The underlying mechanism lies in the mitochondria, the powerhouses of our cells. Normally, mitochondria fuse together to maximize energy-producing efficiency. Silencing MTCH2 disrupts this fusion, causing the mitochondrial network to separate. To compensate for the resulting drop in energy efficiency, the cells scramble for more fuel, turning directly to stored fats.
Crucially, the researchers observed that silencing this protein also blocks immature cells from developing into fully realized, fat-storing cells. In other words, they become immune to obesity.
This double-whammy of boosted metabolic demand and inhibited fat-cell development offers a promising pathway for next-generation obesity therapies that target fat directly while sparing—or even strengthening—muscle tissue.
source: Chourasia, S., Petucci, C., Shoffler, C., & Gross, A. (2025). MTCH2 controls energy demand and expenditure to fuel anabolism during adipogenesis. The EMBO Journal, 44(4), 1007-1038.
